Cost-effectiveness of various maintenance therapies based on mutation status following first-line treatment of primary epithelial ovarian cancer in the United States

2020 ◽  
Vol 159 (2) ◽  
pp. e14
Author(s):  
Courtney Alexis Penn ◽  
Melissa Spring Wong ◽  
Christine Walsh
Keyword(s):  
United States ◽  
Ovarian Cancer ◽  
Cost Effectiveness ◽  
Epithelial Ovarian Cancer ◽  
The United States ◽  
Line Treatment ◽  
First Line ◽  
Mutation Status ◽  
Primary Epithelial Ovarian Cancer ◽  
First Line Treatment

Cost-effectiveness of DTG + ABC/3TC versus EFV/TDF/FTC for first-line treatment of HIV-1 in the United States

2015 ◽  
Vol 18 (10) ◽  
pp. 763-776 ◽  
Author(s):  
Siyang Peng ◽  
Ali Tafazzoli ◽  
Emily Dorman ◽  
Lisa Rosenblatt ◽  
Angelina Villasis-Keever ◽  
...  
Keyword(s):  
United States ◽  
Cost Effectiveness ◽  
The United States ◽  
Line Treatment ◽  
First Line ◽  
Hiv 1 ◽  
First Line Treatment

scholarly journals PIN25 Cost-Effectiveness of Efavirenz Versus Rilpivirine in HIV Patients Initiating First-Line Treatment in the United States

2012 ◽  
Vol 15 (4) ◽  
pp. A241
Author(s):  
M. Bonafede ◽  
T. Juday ◽  
G. Lenhart ◽  
K. Pan ◽  
T. Hebden ◽  
...  
Keyword(s):  
United States ◽  
Cost Effectiveness ◽  
The United States ◽  
Line Treatment ◽  
First Line ◽  
Hiv Patients ◽  
First Line Treatment

scholarly journals Cost-Effectiveness Of Efavirenz Compared With Generic Nevirapine In Hiv Patients Initiating First-Line Treatment In The United States

2013 ◽  
Vol 16 (3) ◽  
pp. A92
Author(s):  
M.M. Bonafede ◽  
T. Juday ◽  
A. Farr ◽  
G.M. Lenhart ◽  
T. Hebden ◽  
...  
Keyword(s):  
United States ◽  
Cost Effectiveness ◽  
The United States ◽  
Line Treatment ◽  
First Line ◽  
Hiv Patients ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document